These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31354629)

  • 1. Proteomics for the Identification of Biomarkers in Testicular Cancer-Review.
    Milardi D; Grande G; Vincenzoni F; Pierconti F; Pontecorvi A
    Front Endocrinol (Lausanne); 2019; 10():462. PubMed ID: 31354629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer proteomics: developments in technology, clinical use and commercialization.
    Yeat NC; Lin C; Sager M; Lin J
    Expert Rev Proteomics; 2015 Aug; 12(4):391-405. PubMed ID: 26145529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics of human seminal plasma: identification of biomarker candidates for fertility and infertility and the evolution of technology.
    Milardi D; Grande G; Vincenzoni F; Castagnola M; Marana R
    Mol Reprod Dev; 2013 May; 80(5):350-7. PubMed ID: 23559416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
    Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
    J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics biomarkers for solid tumors: Current status and future prospects.
    Belczacka I; Latosinska A; Metzger J; Marx D; Vlahou A; Mischak H; Frantzi M
    Mass Spectrom Rev; 2019 Jan; 38(1):49-78. PubMed ID: 29889308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics in prostate cancer biomarker discovery.
    Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
    Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics for early detection of colorectal cancer: recent updates.
    Alnabulsi A; Murray GI
    Expert Rev Proteomics; 2018 Jan; 15(1):55-63. PubMed ID: 29064727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for identifying discriminative isoform-specific peptides for clinical proteomics application.
    Zhang F; Chen JY
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):522. PubMed ID: 27557076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.
    Kolarcik C; Bowser R
    Mol Diagn Ther; 2006; 10(5):281-92. PubMed ID: 17022691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in proteomic prostate cancer biomarker discovery.
    Goo YA; Goodlett DR
    J Proteomics; 2010 Sep; 73(10):1839-50. PubMed ID: 20398807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of proteomics in prostate cancer research: biomarker discovery and validation.
    Pin E; Fredolini C; Petricoin EF
    Clin Biochem; 2013 Apr; 46(6):524-38. PubMed ID: 23266295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary biomarkers in prostate cancer detection and monitoring progression.
    Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
    Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics of cancer of hormone-dependent tissues.
    Tyson DR; Ornstein DK
    Adv Exp Med Biol; 2008; 630():133-47. PubMed ID: 18637489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics.
    Mohri Y; Toiyama Y; Kusunoki M
    Expert Rev Proteomics; 2016 Dec; 13(12):1131-1139. PubMed ID: 27744719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics biomarkers for non-small cell lung cancer.
    Kisluk J; Ciborowski M; Niemira M; Kretowski A; Niklinski J
    J Pharm Biomed Anal; 2014 Dec; 101():40-9. PubMed ID: 25175018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical proteomics and breast cancer.
    Zeidan BA; Townsend PA; Garbis SD; Copson E; Cutress RI
    Surgeon; 2015 Oct; 13(5):271-8. PubMed ID: 25736469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying Clinically Relevant Proteins for Targeted Analysis in the Development of a Multiplexed Proteomic Biomarker Assay.
    Mackay EM; Bathe OF
    Methods Mol Biol; 2018; 1788():123-129. PubMed ID: 29569121
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.